XPO4 has not been directly linked to PC or enzalutamide resistance before, but previous reports have shown that SOX2 facilitates enzalutamide resistance in TP53- and RB1-deficient LNCaP PC cells by promoting lineage plasticity28. The gene discussed is XPO4; the disease is pachyonychia congenita.